tbuckley/cabot-search huggingface dataset:
Adolescent Endocrinology
Authors: Charles W. Lloyd
Journal: JAMA (1971)

This collection of ten contributions (18 authors) deals with some aspects of growth and maturation and disorders of these processes. The papers are generally concerned with limited interests of the authors. Some of them describe the authors' research; some of them are reviews. The book makes no attempt at covering the field of adolescent endocrinology completely. For instance, there is no discussion of sexual precocity or of ovarian failure or menstrual problems. While most of the chapters concentrate on physiological and biochemical factors, others include information about diagnosis and treatment. The attention to literary style and readability varies greatly. Some chapters seem to have been written specifically for this collection and others seem to be transcriptions of lectures; the latter suffer because language acceptable when spoken does not show up well on the written page. The first chapter, by Blizzard and his colleagues, gives a useful summary of the excellent
Manuscripts Approved for JNCI, August-September 1971
Journal: JNCI Journal of the National Cancer Institute (1971)

Journal Article Manuscripts Approved for JNCI, August-September 1971 Get access JNCI: Journal of the National Cancer Institute, Volume 47, Issue 4, October 1971, Pages 911–912, https://doi.org/10.1093/jnci/47.4.911-b Published: 01 October 1971
Disorders of Cobalamin (Vitamin B12) Absorption and Transport
Authors: C. Kapadia
Journal: Annual Review of Medicine (1985)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), emerged in China in December 2019 and quickly spread around the globe, killing more than 4 million people and causing a severe economic crisis. ...Read More
4 Years’ Experience of Head and Neck Tuberculosis in a South London Hospital
Authors: N Choudhury, G Bruch, P Kothari, G Rao, R Simo
Journal: Journal of the Royal Society of Medicine (2005)

In a south London department of otorhinolaryngology and head and neck surgery, 33 cases of tuberculosis were diagnosed in 4 years. The most common presentation was cervical adenitis (58%) and in some cases the initial investigations suggested malignant disease. Most of the patients were of non-British origin but none proved to be HIV seropositive. Fine-needle aspiration was positive for tuberculosis in 7 of 19 patients. 21 patients required a surgical procedure for diagnosis.
Primary prevention of hypertension by nutritional-hygienic means. Final report of a randomized, controlled trial
Authors: R. Stamler
Journal: JAMA (1989)

A 5-year trial involving 201 men and women with high-normal blood pressure at baseline demonstrated the ability to reduce the incidence of hypertension in participants randomized to nutritional-hygienic intervention compared with a control group. The incidence of hypertension was 8.8% among 102 intervention group participants vs 19.2% among 99 control group members. The odds ratio for the incidence of hypertension in the control group was 2.4. Mean trial blood pressure also was lower in the intervention compared with the control group ( -1.2 and -1.9 mm Hg, respectively, for diastolic blood pressure at work-site and office visits and -1.3 and - 2.0 mm Hg, respectively, for systolic blood pressure at the two sites). Net weight loss in the intervention group averaged 2.7 kg during the trial; sodium intake was reduced by 25% and reported alcohol intake decreased by 30%. The majority of intervention participants also reported an increase in physical activity. Effect on blood pressure was related particularly to degree of weight loss. Results indicate that even a moderate reduction in risk factors for hypertension among hypertension-prone individuals contributes to the primary prevention of the disease. (<i>JAMA</i>. 1989;262:1801-1807)
From the Food and Drug Administration
Authors: S. L. Nightingale
Journal: JAMA (1995)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2024 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Short-term therapy for streptococcal infective endocarditis. Combined intramuscular administration of penicillin and streptomycin
Authors: W. R. Wilson
Journal: JAMA (1981)

In a prospective study, 91 patients with penicillin-sensitive infective endocarditis (IE) were treated for two weeks with intramuscular (IM) penicillin G procaine, 1.2 million units every six hours, plus streptomycin sulfate, 500 mg IM every 12 hours. Viridans streptococci were isolated from 70 patients (77%); 21 patients (23%) had<i>Streptococcus bovis</i>infections. Eighteen patients (20%) had had symptoms of IE for three months or longer. Follow-up ranged from two months to 6.6 years. There were no relapses; mild vestibular toxic reactions occurred in two patients (2%). Two patients (2%) died—one of sudden-onset severe heart failure and one of cardiac arrest after aortic valve replacement. Twenty-six patients (19%) required cardiac valve replacement after completion of antimicrobial therapy. This therapy seems as efficacious as four weeks of parenteral antimicrobial therapy and is more cost-effective. (<i>JAMA</i>1981;245:360-363)
Acute Respiratory Infection in Children: I. Intensive Study of Etiology in Open Community
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
In Brief
Journal: JAMA (1977)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Abstract 2432: Prevalence of depression and other chronic diseases among uninsured cancer survivors: A free clinic study
Authors: Sayeef Mirza, Shams Rahman, Madeline Macdonald, Alexandra Towne, Katherine Robinson, Amber Todd, Wei Wang, Deanna Wathington
Journal: Cancer Research (2019)

Abstract Introduction: Free clinics play an important role in providing health care services to the poor and uninsured. Limited data exist on chronic disease burden and patient characteristics of cancer survivors outside the network of insured health systems. In this study we describe characteristics of cancer patients utilizing free clinics for chronic disease management and mental health services in order to evaluate associations between chronic conditions. Methods: Nine free clinics in the Tampa Bay area were included in this study. A retrospective review of patient charts from 01/01/2016 to 12/31/2017 was conducted. Data on patient characteristics and prevalence of chronic diseases were abstracted through an online questionnaire using Redcap software. Patients with a documented history of cancer were considered cancer survivors. Chi-square test was used to compare patient characteristics and p-values were reported. Logistic regressions were used to examine associations between diseases and socio-demographic factors. Odds ratios (OR) and 95% confidence intervals (CI) were reported. Results: From 2016 to 2017, 208 cancer survivors were managed in nine free clinics. The average age was 54 years and 138 (66%) were women. The prevalence of depression was 11.14%. The prevalence of depression was higher among women (12.7%) compared to men (8.8%), p-value 0.001. The prevalence was significantly highest among patients who were 18-44 years, non-Hispanics, white race, unemployed and considered low-income. In univariate analyses, the prevalence of depression was significantly associated with cancer (OR 2.12; 95%CI: 1.23-3.67), diabetes (OR 1.59; 95%CI: 1.21-2.08), cerebrovascular accident (OR 3.25; 95%CI: 1.71-6.21), cardiovascular disease (OR 2.10; 95%CI: 1.26-3.51), hypertension (OR 1.96; 95%CI: 1.58-2.43), and hyperlipidemia (OR 2.30; 95%CI: 1.79-2.94). Unemployment, lower income level, and higher BMI were also factors positively associated with the prevalence of depression. Additional relationships and multivariate analyses are available. Conclusion: Despite having access to limited resources, free clinics receive mainly poor, women, middle-aged, and uninsured patients. Comorbidities such as cancer and other chronic conditions are often directly associated with depression among patients managed in free clinics. Mental health support is critically needed in free clinics, especially for those who are cancer survivors. Citation Format: Sayeef Mirza, Shams Rahman, Madeline Macdonald, Alexandra Towne, Katherine Robinson, Amber Todd, Wei Wang, Deanna Wathington. Prevalence of depression and other chronic diseases among uninsured cancer survivors: A free clinic study [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 2432.
Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(- )-inhibitor complexes in sepsis
Authors: JH Nuijens, CC Huijbregts, AJ Eerenberg-Belmer, JJ Abbink, RJ Strack van Schijndel, RJ Felt-Bersma, LG Thijs, CE Hack
Journal: Blood (1988)
<i>Jahresbericht der niederoesterreichischen Landesirrenanstalten, Wien, Ybbs, Klosterneuburg und Kierling-Gugging, der niederoesterreichischen Landes-Irrenzweiganstalt in Langenlois, sowie der sonstigen Anstalten zur Unterbringung Geistesgestoerter Niederoesterreichischer Landespfleglinge pro 1891-92. Ausgegeben vom niederoesterreichischen Landesaussechuss.</i>[Annual Report of Nether-Austrian Institutions for the Insane for 1891-2.]
Journal: American Journal of Psychiatry (1893)
Clinical Cytopathology for Pathologlsts—Postgraduate Course
Journal: JNCI Journal of the National Cancer Institute (1978)

Clinical Cytopathology for Pathologlsts—Postgraduate Course Get access JNCI: Journal of the National Cancer Institute, Volume 61, Issue 5, November 1978, Page 1367, https://doi.org/10.1093/jnci/61.5.1367-a Published: 01 November 1978
Dialysis therapy for psoriasis
Authors: T. J. Buselmeier
Journal: JAMA (1978)

PSORIASIS affects approximately 3% of the population. It has been treated with topical steroids, tar or tar derivatives alone or in combination with ultraviolet B light, or photosensitizing psoralen compounds in combination with ultraviolet A light. Oral antimetabolites may be effective but are associated with deleterious side effects. So far, to our knowledge, three patients with severe psoriasis have responded to dialytic therapy.<sup>1,2</sup>A fourth patient had intractable psoriasis that resolved during the course of hemodialysis. <h3>Report of a Case</h3> A 51-year-old woman was hospitalized at the University of Minnesota Hospitals with renal failure secondary to polycystic kidney disease. She complained of fatigue, lethargy, weakness, anorexia, and some nausea associated with her renal disease. Her skin problems had begun 16 years earlier when she noted scaling on her face and scalp that gradually progressed to involve the nose, ears, neck, buttock, abdomen, and knees. Two of the nails of
Plenty of fuel for Agent Orange dispute
Authors: P. Gunby
Journal: JAMA (1979)

More studies are under way or planned in the Agent Orange controversy. The latest study will be conducted by the US Air Force beginning in October and will focus on an intensively exposed population: military personnel who sprayed the defoliant on Vietnam's jungles from the air for more than eight years so as to deny cover and food crops to the enemy. Agent Orange contains 2,4,5-trichlorophenoxyacetic acid (2,4,5-T), a synthetic growth-regulating compound that has been used as a herbicide since 1944 in the United States and elsewhere because it can kill broadleaf plants by overstimulating their phototropic response. The Environmental Protection Agency (EPA) banned most herbicidal uses in this country five months ago, citing "a high miscarriage rate [130 spontaneous abortions within three months] following the spraying of 2,4,5-T in forests around Alsea, Ore." There continue to be widely varying opinions about the Alsea Basin data and about other possible
Cockroach
Authors: Jack Coulehan
Journal: Annals of Internal Medicine (2002)

Ad Libitum17 December 2002CockroachJack Coulehan, MDJack Coulehan, MDSetauket, NY 11733Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-137-11-200212030-00012 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail her interest first perked when visiting a luxury apartment in Barbados where she noticed the bugs were not only more speckled and slower than the ones she grew up with, but big enough to use in her experiments. Forty years later she knows ... Author, Article, and Disclosure InformationAffiliations: Setauket, NY 11733Current Author Address: Jack Coulehan, MD, 4 Townsend Court, Setauket, NY 11733. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 17 December 2002Volume 137, Issue 12Page: 1006KeywordsEmotionsFear ePublished: 17 December 2002 Issue Published: 17 December 2002 Copyright & PermissionsCopyright © 2002 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
TAGLN2 regulates T cell activation by stabilizing the actin cytoskeleton at the immunological synapse
Authors: B Na, H Kim, I. Piragyte, H Oh, M Kwon, U. Akber, H Lee, D Park, W Song, Z Park, S Im, M Rho, Y Hyun, M. Kim, Chang-Duk Jun
Journal: The Journal of Experimental Medicine (2015)

Extracellular vesicles (EVs), such as exosomes and microvesicles, are released by different cell types and participate in physiological and pathophysiological processes.EVs mediate intercellular communication as cell-derived extracellular signalling organelles that transmit specific information from their cell of origin to their target cells.As a result of these properties, EVs of defined cell types may serve as novel tools for various therapeutic approaches, including (a) anti-tumour therapy, (b) pathogen vaccination, (c) immune-modulatory and regenerative therapies and (d) drug delivery.The translation of EVs into clinical therapies requires the categorization of EV-based therapeutics in compliance with existing regulatory frameworks.As the classification defines subsequent requirements for manufacturing, quality control and clinical investigation, it is of major importance to define whether EVs are considered the active drug components or primarily serve as drug delivery vehicles.For an effective and particularly safe translation of EV-based therapies into clinical practice, a high level of cooperation between researchers, clinicians and competent authorities is essential.In this position statement, basic and clinical scientists, as members of the International Society for Extracellular Vesicles (ISEV) and of the European Cooperation in Science and Technology (COST) program of the European Union, namely European Network on Microvesicles and Exosomes in Health and Disease (ME-HaD), summarize recent developments and the current knowledge of EV-based therapies.Aspects of safety and regulatory requirements that must be considered for pharmaceutical manufacturing and clinical application are highlighted.Production and quality control processes are discussed.Strategies to promote the therapeutic application of EVs in future clinical studies are addressed.
Prevention of Migraine
Journal: JAMA (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Table of Contents
Authors: Sabine Westphal, Katrin Borucki, Elena Taneva, Ruma Makarova, Claus Luley, Mitsugu Yamanaka, Yasushi Itakura, Tadashi Inoue, Atsushi Tsuchida, Tsutomu Nakagawa, Hiroshi Noguchi, Mutsuo Taiji, Sofia Tsouli, Evangelos Liberopoulos, Dimitri Mikhailidis, Vasilios Athyros, Moses Elisaf, Krista Varady, Benoît Lamarche, Sylvia Santosa, Isabelle Demonty, Amélie Charest, Peter Jones, Davide Noto, Manfredi Rizzo, Carlo Barbagallo, Angelo Cefalù, Alessia Verde, Francesca Fayer, Alberto Notarbartolo, Maurizio Averna, Jayanta Choudhury, Faridoddin Mirshahi, Karnam Murthy, Dorne Yager, Arun Sanyal, Masao Kanauchi, Kimiko Kanauchi, Kuniko Kimura, Tomoko Inoue, Yoshihiko Saito, Ellen Engelson, Denise Agin, Sonjia Kenya, Galila Werber-Zion, Besa Luty, Jeanine Albu, Donald Kotler, Finn Von Eyben, Ejvind Mouritsen, Jan Holm, Georg Dimcevski, Paulius Montvilas, Gabriel Suciu, Eun-Jung Rhee, Ki-Won Oh, Won-Young Lee, Se-Yeon Kim, Chan-Hee Jung, Byung-Jin Kim, Ki-Chul Sung, Su Kim, Jin-Ho Kang, Man-Ho Lee, Sun-Woo Kim, Jung-Roe Park, Yukinori Isomura, Tomoatsu Mune, Hiroyuki Morita, Tetsuya Suwa, Nobuki Takada, Yoritsuna Yamamoto, Jun Takeda, Helena Santa-Clara, Linda Szymanski, Vikkie Mustad, Stephen Demichele, Yung-Sheng Huang, Amanda Mika, Nathan Lubbers, Nathalie Berthiaume, Jim Polakowski, Brad Zinker, Jan Polak, Eva Klimcakova, Cedric Moro, Nathalie Viguerie, Michel Berlan, Jindriska Hejnova, Blanka Richterova, Ivan Kraus, Dominique Langin, Vladimir Stich, Paul Araiza, Hilary Hewes, Carrie Gashetewa, Chantal Vella, Mark Burge, Simona Kratochvílová, Pavlína Vyhnanovská, Zuzana Vlasáková, Milan Hájek, Jelena Skibová, Terezie Pelikánová, Christian Carpéné, Danièle Daviaud, Jeremie Boucher, Sandy Bour, Virgile Visentin, Sandra Grès, Carine Duffaut, Emi Fontana, Xavier Testar, Jean-Sébastien Saulnier-Blache, Philippe Valet, Keiji Yoshioka, Toshihide Yoshida, Yasuto Takakura, Tsunekazu Umekawa, Akinori Kogure, Hitoshi Toda, Toshikazu Yoshikawa, Yin Liang, Pengxiang She, Xiwei Wang, Keith Demarest, Johanna Vartiainen, Y Kesäniemi, Olavi Ukkola, Maria Calsolari, Leonardo Oliveira Medina, Elaine Cunha, Clara Veloso, Miriam Chaves, Adriana Bosco, José Nogueira-Machado
Journal: Metabolism (2006)
Who is a specialist?
Journal: JAMA (1969)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal